Pant Swati, Gupta Mohan, Anthwal Tulika, Chauhan Monika, Nain Sumitra
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Tonk, Rajasthan, India.
Lab Anim Res. 2024 Mar 11;40(1):9. doi: 10.1186/s42826-023-00187-y.
Alzheimer's disease (AD), the most common form of progressive dementia in the elderly, is a chronic neurological disorder that decreases cognitive ability. Although the underlying cause of AD is yet unknown, oxidative stress and brain acetylcholine shortage are the key pathogenic causes.
The current study shows that these derivatives have the potential to improve memory in mice by inhibiting scopolamine-induced acetylcholinesterase activity, oxidative and nitrosative stress, and improving locomotor activity and muscle grip strength in the rota rod test. When compared to the illness control, the memory-enhancing potential of novel N-benzyl pyridine-2-one derivatives was highly significant (P < 0.0001).
The observed memory ameliorating effect of novel N-benzyl pyridine-2-one makes them as a a good choice for treatment of individuals with cognitive impairment.
阿尔茨海默病(AD)是老年人中最常见的进行性痴呆形式,是一种会降低认知能力的慢性神经疾病。尽管AD的潜在病因尚不清楚,但氧化应激和脑内乙酰胆碱缺乏是关键的致病原因。
当前研究表明,这些衍生物有潜力通过抑制东莨菪碱诱导的乙酰胆碱酯酶活性、氧化应激和亚硝化应激,并在转棒试验中改善运动活性和肌肉握力,从而改善小鼠的记忆力。与疾病对照组相比,新型N-苄基吡啶-2-酮衍生物的记忆增强潜力非常显著(P < 0.0001)。
新型N-苄基吡啶-2-酮所观察到的记忆改善作用使其成为治疗认知障碍个体的良好选择。